Schedule 13G ownership disclosure
Silence Therapeutics plc
Ordinary Shares, par value GBP 0.05 per share (the "Shares") · CUSIP: G8128Y157
Event date: 2025-12-31
- Filing-level shares
- 5,935,955
- Percent of class
- 4.2%
- Lombard Odier Asset Management (USA) Corp
Shares: 5,935,955 · Class: 4.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000908834-26-000072
- Form type
- SCHEDULE 13G/A
- Filer
- Lombard Odier Asset Management (USA) Corp
- CIK
- CIK 1491719
- Filed
- Feb 09, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership